10x Genomics, Inc. - 8-K Filing
On June 4, 2026, 10x Genomics held its annual stockholder meeting where three Class I directors were elected with majority support. Shareholders also ratified Ernst & Young LLP as the independent auditor and approved executive compensation on a non-binding advisory basis. (Items: 5.07 Submission of Matters to a Vote of Security HoldersThe annual meeting of stockholders of 10x Genomics, Inc)
Tickers: $TXG